ANDREA NGUYEN: Open Payments
NPI 1255615761 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348,049 in 779 payments from 27 companies in 2025. Trend: 2023 $199,470 · 2024 $294,429 · 2025 $348,049
Speaker / faculty: $174,833Consulting: $64,123Travel & lodging: $58,693Honoraria: $30,338Food & beverage: $14,952Speaker / faculty: $4,932
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 107 | $51,964 |
| Janssen Biotech, Inc. | 71 | $51,370 |
| Organon LLC | 52 | $33,542 |
| Arcutis Biotherapeutics, Inc. | 61 | $29,215 |
| Amgen Inc. | 49 | $27,960 |
| Lilly USA, LLC | 52 | $26,929 |
| Eli Lilly and Company | 31 | $19,871 |
| GENZYME CORPORATION | 28 | $16,799 |
| UCB, Inc. | 25 | $16,623 |
| ABBVIE INC. | 52 | $9,833 |
Products named: Opzelura, TREMFYA, EBGLYSS, VTAMA, Zoryve, OTEZLA, DUPIXENT, Bimzelx.
Industry payments across CA — which companies pay providers there.
